22157.jpg
Global Checkpoint Inhibitors Market (2021 to 2030) - Featuring AstraZeneca, Roche Holding and Pfizer Among Others
December 07, 2021 06:58 ET | Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Global Head and Neck Squamous Cell Carcinoma Drug Market Report 2021: Limited R&D in HNSCC, Resulting in a Market with Little Competition and a Stagnant Pipeline - Market Will Grow to $5.2B in 2030
November 08, 2021 05:53 ET | Research and Markets
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market
October 14, 2021 07:13 ET | Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
22157.jpg
Global Checkpoint Inhibitor Refractory Cancer Market Report 2021: Marketed Therapies, Emerging Therapies, Checkpoint Inhibitors, Major Markets, Epidemiology - Forecast to 2030
August 17, 2021 03:38 ET | Research and Markets
Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitor Refractory Cancer - Market Insights, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
visiongain Logo.png
Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Research Inc.
August 02, 2021 12:00 ET | Visiongain Ltd
Visiongain has published a new report: Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031: Forecasts by Category (PD1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Cytokines Targets,...
22157.jpg
Global Peptide Based Cancer Therapeutics Market Share, Size, Trends Analysis Report, Featuring AstraZeneca PLC, Abbott, Allergan plc and Pfizer Inc.
April 27, 2021 04:38 ET | Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Cancer Type; By Mode of Mechanism, By...
22157.jpg
Immunotherapy Drugs: Global Markets Through 2019, 2020, and 2021-2025
March 29, 2021 06:38 ET | Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global immunotherapy market can be segmented...
Emergen logo.png
Immunotherapy Drugs Market Size to Reach USD 365.57 Billion by 2027 | Rising Advent of Biologics and Increasing Demand for Monoclonal Antibodies are Significant Factors Influencing Industry Growth, says Emergen Research
March 01, 2021 18:00 ET | Emergen Research
Vancouver, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- The global immunotherapy drugs market is projected to reach value of USD 365.57 Billion by 2027, according to a current analysis by...
Emergen logo.png
Oncolytic Virus Therapy Market Size to Reach USD 866.1 Million by 2028 | Growing Awareness About Early Cancer Detection is a Significant Factor Driving Industry Growth, says Emergen Research
February 23, 2021 09:08 ET | Emergen Research
Vancouver, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to...
22157.jpg
$135 Billion Immuno-Oncology Markets, 2024
January 07, 2021 08:13 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market, by Type (mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)), by Application (Lung,...